急性心肌梗死合并心源性休克的临床干预治疗

Clinic therapies of acute myocardial infarction complicated by cardiogenic shock

心源性休克是急性心肌梗死患者的严重合并症,病死率高。针对临床治疗,一般辅助治疗是基本干预措施,早期血运再通是最重要的干预措施,血管活性药物的合理应用可稳定血流动力学,机械性辅助装置的合理应用可有效改善预后,但上述措施均缺乏指南和完整研究证据支持。本文综合整理归纳了针对急性心肌梗死合并心源性休克的现有干预策略,以期为临床治疗提供参考。

Cardiogenic shock is a serious complication in patients with acute myocardial infarction, and the mortality is high. For clinical treatment, general adjuvant therapy is the basic intervention measures, early blood reperfusion is the most important intervention measures, rational use of vasoactive drugs can stabilize the hemodynamics, mechanical auxiliary device can effectively improve the prognosis, but these measures are lack of guidelines and complete research evidence. This paper summarizes the current intervention strategies for acute myocardial infarction complicated with eardiogenic shock, in order to provide reference for clinical treatment.